HONG GAO, M.D.
Student, Health Care at Highland Ave, Salem, MA

License number
Massachusetts 245313
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Massachusetts 245313
Category
Student, Health Care
Type
Student in an Organized Health Care Education/Training Program
Address
Address 2
81 Highland Ave, Salem, MA 01970
800 Washington St, Boston, MA 02111
Phone
(978) 354-4009
(617) 636-1083

Personal information

See more information about HONG GAO at radaris.com
Name
Address
Phone
Hong Gao
54 Berlin St #56, Quincy, MA 02170
(617) 328-1952
Hong Gao, age 67
134 Lowell St, Lexington, MA 02420
Hong Gao, age 56
241 South Rd, Bedford, MA 01730
(781) 254-8301
Hong Gao
2301 Halcyon Dr, Worcester, MA 01606
(508) 380-9106
Hong Gao
9 Lincoln St, Somerville, MA 02145

Organization information

See more information about HONG GAO at bizstanding.com

Hong Gao MD

81 Highland Ave, Salem, MA 01970

Industry:
Internist
Phone:
(978) 354-4009 (Phone)
Hong Gao

Professional information

See more information about HONG GAO at trustoria.com
Hong Gao Photo 1
Recombinant Expression Vector Elements (Reves) For Enhancing Expression Of Recombinant Proteins In Host Cells

Recombinant Expression Vector Elements (Reves) For Enhancing Expression Of Recombinant Proteins In Host Cells

US Patent:
7935808, May 3, 2011
Filed:
Mar 28, 2008
Appl. No.:
12/079748
Inventors:
Wendy R. Gion - Charlton MA, US
Gerald R. Carson - Belmont MA, US
Hong Gao - Allston MA, US
Yune Z. Kunes - Winchester MA, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07H 21/04, C12N 15/74, A61K 48/00
US Classification:
536 241, 424 932, 424 9321, 4353201, 536 231, 514 44
Abstract:
Compositions and methods comprising recombinant expression vector elements (rEVEs) to enhance the level of expression of recombinant proteins are described. Other compositions and methods for lowering, substantially suppressing, or essentially silencing expression of a recombinant protein are also described.


Hong Gao Photo 2
Recombinant Expression Vector Elements (Reves) For Enhancing Expression Of Recombinant Proteins In Host Cells

Recombinant Expression Vector Elements (Reves) For Enhancing Expression Of Recombinant Proteins In Host Cells

US Patent:
8410259, Apr 2, 2013
Filed:
Apr 29, 2011
Appl. No.:
13/098337
Inventors:
Wendy R. Gion - Charlton MA, US
Gerald R. Carson - Belmont MA, US
Hong Gao - Allston MA, US
Yune Z. Kunes - Winchester MA, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07H 21/04, C12N 15/74
US Classification:
536 241, 536 231, 424 932, 424 9321, 4353201
Abstract:
Compositions and methods comprising recombinant expression vector elements (rEVEs) to enhance the level of expression of recombinant proteins are described. Other compositions and methods for lowering, substantially suppressing, or essentially silencing expression of a recombinant protein are also described.


Hong J Gao Photo 3
Dr. Hong J Gao, Boston MA - MD (Doctor of Medicine)

Dr. Hong J Gao, Boston MA - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
800 Washington St, Boston 02111
(617) 636-5000 (Phone), (617) 636-8319 (Fax)
NORTH SHORE MEDICAL CENTER
81 Highland Ave, Salem 01970
(978) 741-1200 (Phone), (978) 740-4752 (Fax)
81 Highland Ave, Salem 01970
(978) 354-4009 (Phone)
Languages:
English


Hong Gao Photo 4
Treatment Of Cellular Proliferative Disorders With Compositions Comprising Hom Polypeptide (Also Known As Xom, Ventx2)

Treatment Of Cellular Proliferative Disorders With Compositions Comprising Hom Polypeptide (Also Known As Xom, Ventx2)

US Patent:
7994126, Aug 9, 2011
Filed:
Feb 22, 2007
Appl. No.:
11/677828
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
A61K 38/00
US Classification:
514 79
Abstract:
Disclosed are compositions comprising Hom polypeptide (also known as Xom, Ventx2) and methods for treating cellular proliferative disorders comprising. Also disclosed are diagnosis methods, prognosis methods, and drug screening methods.


Hong Gao Photo 5
Expanding Hematopoietic Stem Cells

Expanding Hematopoietic Stem Cells

US Patent:
2012016, Jun 28, 2012
Filed:
Nov 23, 2011
Appl. No.:
13/303675
Inventors:
Hong Gao - Allston MA, US
Zhenglun Zhu - Allston MA, US
International Classification:
A61K 35/12, A61K 35/28, A61P 7/00, C12Q 1/68, A61P 43/00, A61P 7/06, C12N 5/0789, A61K 35/14
US Classification:
424 937, 435375, 435 612, 435 61
Abstract:
A method of expanding hematopoietic stem cells. Also disclosed is a method of diagnosing primary or secondary bone marrow failure syndrome. The invention further includes a method of treating primary or secondary bone marrow failure syndrome.


Hong Gao Photo 6
Treatment Of Development-Related Disorders

Treatment Of Development-Related Disorders

US Patent:
2011030, Dec 8, 2011
Filed:
Aug 9, 2011
Appl. No.:
13/206003
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
C12Q 1/68
US Classification:
435 612, 435 614
Abstract:
Disclosed are composition and methods for treating development-related disorders. Also disclosed are diagnosis methods, prognosis methods, and drug screening methods.


Hong Gao Photo 7
Treatment Of Development-Related Disorders

Treatment Of Development-Related Disorders

US Patent:
2013028, Oct 24, 2013
Filed:
Apr 9, 2013
Appl. No.:
13/859285
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
C12Q 1/68
US Classification:
4241391, 435 612, 514 44 A
Abstract:
Disclosed are composition and methods for treating development-related disorders. Also disclosed are diagnosis methods, prognosis methods, and drug screening methods.


Hong Gao Photo 8
Treatment And Diagnosis Of Immune Disorders

Treatment And Diagnosis Of Immune Disorders

US Patent:
2012018, Jul 19, 2012
Filed:
Jul 15, 2010
Appl. No.:
13/382641
Inventors:
Zhenglun Zhu - Allston MA, US
Hong Gao - Allston MA, US
International Classification:
A61K 39/395, A61K 31/573, A61K 31/7088, A61K 31/52, A61K 31/519, G01N 21/64, A61P 29/00, A61P 11/00, A61K 38/17, C07K 14/47, C07K 16/18, C12Q 1/68, C07H 21/04, A61K 31/5377
US Classification:
4241391, 536 245, 514179, 514 44 A, 5142632, 514250, 5142335, 514 212, 514 44 R, 514 213, 536 2431, 536 2433, 530350, 5303879, 435 612, 436501
Abstract:
Disclosed are composition and methods for treating immune disorders. Also disclosed are diagnosis methods and prognosis methods.